The Edwards EVOQUE tricuspid valve replacement system became the first transcatheter therapy to receive FDA approval for treating tricuspid regurgitation.
A new non-surgical treatment provides relief for people with osteoarthritis in the knee who are not ready, or are not candidates, for knee replacement surgery.
